Andrew Huberman· PhD
but the absolute rate is still really really low
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
but the absolute rate is still really really low
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
The more recent study looked as long as 14 years out out and there they found measurable statistically significant increase in risk that increased during the first 3 years of being on a stimulant and increased at a much lower rate for the next 10 years sort of plateaued out but still measurably higher than people with ADHD who weren't on a stimulant
most the studies looking at more serious other than just mild hypertension or mild elevation of heart rate um haven't found much but most of them only looked you know a year out or a year of treatment do we see rates of heart attacks do we see rates of Strokes do we see rates of dangerous arrhythmias and in general they're looking at a young population where these events are really uncommon anyway and most of them didn't find any evidence of problems in a year or two out